Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Transarterial Delivery of a Biodegradable Single-Agent Theranostic Nanoprobe for Liver Tumor Imaging and Combinatorial Phototherapy.

Taratula OR, Taratula O, Han X, Jahangiri Y, Tomozawa Y, Horikawa M, Uchida B, Albarqi HA, Schumann C, Bracha S, Korzun T, Farsad K.

J Vasc Interv Radiol. 2019 Jun 12. pii: S1051-0443(19)30297-0. doi: 10.1016/j.jvir.2019.03.004. [Epub ahead of print]

PMID:
31202675
2.

Characterization of Iodide-induced Sialadenitis: Meta-analysis of the Published Case Reports in the Medical Literature.

Jiao A, Farsad K, McVinnie DW, Jahangiri Y, Morrison JJ.

Acad Radiol. 2019 Jun 6. pii: S1076-6332(19)30243-0. doi: 10.1016/j.acra.2019.05.006. [Epub ahead of print] Review.

3.

Percutaneous Transmesenteric Portal Vein Recanalization and Transjugular Direct Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Occlusion.

Farsad K, Zaman A.

J Vasc Interv Radiol. 2019 Jun;30(6):892-893. doi: 10.1016/j.jvir.2019.02.003. No abstract available.

PMID:
31126601
4.

ACR Appropriateness Criteria® Radiologic Management of Venous Thromboembolism-Inferior Vena Cava Filters.

Expert Panel on Interventional Radiology:, Minocha J, Smith AM, Kapoor BS, Fidelman N, Cain TR, Caplin DM, Eldrup-Jorgensen J, Farsad K, Gupta A, Lee MH, McBride JJ, Moores LK, Rochon PJ, Lorenz JM.

J Am Coll Radiol. 2019 May;16(5S):S214-S226. doi: 10.1016/j.jacr.2019.02.010.

PMID:
31054748
5.

Muscle Gain after Transjugular Intrahepatic Portosystemic Shunt Creation: Time Course and Prognostic Implications for Survival in Cirrhosis.

Jahangiri Y, Pathak P, Tomozawa Y, Li L, Schlansky BL, Farsad K.

J Vasc Interv Radiol. 2019 Jun;30(6):866-872.e4. doi: 10.1016/j.jvir.2019.01.005. Epub 2019 Apr 30.

PMID:
31053265
6.

Palmar Warming for Radial Artery Vasodilation to Facilitate Transradial Access: A Randomized Controlled Trial.

Al-Hakim R, Hedge JC, Jahangiri Y, Kaufman JA, Galuppo R, Farsad K.

J Vasc Interv Radiol. 2019 Mar;30(3):421-424. doi: 10.1016/j.jvir.2018.10.021.

PMID:
30819486
7.

Venous Stenosis Animal Model Utilizing Endovenous Radiofrequency Ablation.

Al-Hakim RA, Kaufman JA, Jahangiri Y, Uchida BT, Farsad K.

J Vasc Interv Radiol. 2019 Feb;30(2):271-273. doi: 10.1016/j.jvir.2018.08.012. No abstract available.

PMID:
30717966
8.

Applications of nanoparticles in biomedical imaging.

Han X, Xu K, Taratula O, Farsad K.

Nanoscale. 2019 Jan 17;11(3):799-819. doi: 10.1039/c8nr07769j. Review.

PMID:
30603750
9.

Tailored treatment of patients with hepatocellular carcinoma with portal vein invasion: experience from a multidisciplinary hepatobiliary tumor program within a NCI comprehensive cancer center.

Walcott-Sapp S, Naugler S, Lim JY, Wagner J, Orloff SL, Farsad K, Kolbeck KJ, Kaufman J, Maynard E, Enestvedt CK, Mayo SC, Billingsley KG.

J Gastrointest Oncol. 2018 Dec;9(6):1074-1083. doi: 10.21037/jgo.2018.08.11.

10.

Early Venous Stent Failure Predicted by Platelet Count and Neutrophil/Lymphocyte Ratio.

Jahangiri Y, Endo M, Al-Hakim R, Kaufman JA, Farsad K.

Circ J. 2019 Jan 25;83(2):320-326. doi: 10.1253/circj.CJ-18-0592. Epub 2018 Dec 14.

11.

Intravascular US Guidance for Direct Intrahepatic Portosystemic Shunt Creation in the Setting of Polycystic Liver Disease.

Hedge JC, Foulke E, Farsad K.

J Vasc Interv Radiol. 2018 Oct;29(10):1476-1477. doi: 10.1016/j.jvir.2017.11.025. No abstract available.

PMID:
30266228
12.

Antiplatelet Therapy is Associated with Stent Patency After Iliocaval Venous Stenting.

Endo M, Jahangiri Y, Horikawa M, Kaufman JA, Schenning RC, Kolbeck KJ, Barton RE, Ohuchi Y, Liang KW, Farsad K.

Cardiovasc Intervent Radiol. 2018 Nov;41(11):1691-1698. doi: 10.1007/s00270-018-2062-5. Epub 2018 Aug 17.

PMID:
30120531
13.

Effects of Different Mixing Agents on the Stability of Sodium Tetradecyl Sulfate (STS) Foam: An Experimental Study.

Hashimoto K, Uchida B, Horikawa M, Mimura H, Farsad K.

Cardiovasc Intervent Radiol. 2018 Dec;41(12):1952-1957. doi: 10.1007/s00270-018-2049-2. Epub 2018 Aug 7.

PMID:
30088060
14.

Skin ischemia and ulceration as a complication of inferior phrenic artery embolization for hepatocellular carcinoma.

Koh S, Maki EJ, Kolbeck KJ, Farsad K.

Radiol Case Rep. 2018 Apr 5;13(3):648-651. doi: 10.1016/j.radcr.2018.02.032. eCollection 2018 Jun.

15.

Variant May-Thurner syndrome: Compression of the left common iliac vein by the ipsilateral internal iliac artery.

Sharafi S, Farsad K.

Radiol Case Rep. 2018 Feb 20;13(2):419-423. doi: 10.1016/j.radcr.2018.01.001. eCollection 2018 Apr.

16.

Iliac Vein Stent Placement: Acute Venographic Changes and Relevance to Venous Biomechanics.

Al-Hakim RA, Kaufman JA, Farsad K.

J Vasc Interv Radiol. 2018 Jul;29(7):1023-1027. doi: 10.1016/j.jvir.2018.02.031. Epub 2018 May 30.

PMID:
29859663
17.

90Y Radioembolization for Hepatic Malignancy in Patients with Previous Biliary Intervention: Multicenter Analysis of Hepatobiliary Infections.

Devulapalli KK, Fidelman N, Soulen MC, Miller M, Johnson MS, Addo E, El-Haddad G, Nutting C, Morrison J, Farsad K, Lokken RP, Gaba RC, Fleming J, Brown DB, Kwan SW, Rose SC, Pennycooke KA, Liu DM, White SB, Gandhi R, Lazar AA, Kerlan RK Jr.

Radiology. 2018 Sep;288(3):774-781. doi: 10.1148/radiol.2018170962. Epub 2018 May 8.

PMID:
29737954
18.

Long-Term Toxicity after Transarterial Radioembolization with Yttrium-90 Using Resin Microspheres for Neuroendocrine Tumor Liver Metastases.

Tomozawa Y, Jahangiri Y, Pathak P, Kolbeck KJ, Schenning RC, Kaufman JA, Farsad K.

J Vasc Interv Radiol. 2018 Jun;29(6):858-865. doi: 10.1016/j.jvir.2018.02.002. Epub 2018 Apr 30.

PMID:
29724520
19.

ACR Appropriateness Criteria® Abdominal Aortic Aneurysm: Interventional Planning and Follow-Up.

Expert Panels on Vascular Imaging and Interventional Radiology:, Francois CJ, Skulborstad EP, Majdalany BS, Chandra A, Collins JD, Farsad K, Gerhard-Herman MD, Gornik HL, Kendi AT, Khaja MS, Lee MH, Sutphin PD, Kapoor BS, Kalva SP.

J Am Coll Radiol. 2018 May;15(5S):S2-S12. doi: 10.1016/j.jacr.2018.03.008.

PMID:
29724423
20.

Hepatocellular Carcinoma With Portal Venous Invasion: Radiating New Hope?

Farsad K, Costentin CE, Zhu AX.

JAMA Oncol. 2018 May 1;4(5):669-670. doi: 10.1001/jamaoncol.2018.0007. No abstract available.

PMID:
29543953
21.

Erratum to "Arteriopathy after transarterial chemo-lipiodolization for hepatocellular carcinoma" [Diagn. Interv. Imaging 98 (12) (2017) 827-35].

Matsui Y, Figi A, Horikawa M, Jahangiri Noudeh Y, Tomozawa Y, Hashimoto K, Kaufman JA, Farsad K.

Diagn Interv Imaging. 2018 Mar;99(3):183-184. doi: 10.1016/j.diii.2018.01.015. Epub 2018 Feb 16. No abstract available.

22.

VIDEO: Technique to Restrict the Gore Viatorr Stent-Graft for TIPS Reduction.

Geeratikun Y, Timmermans H, Uchida B, Jahangiri Y, Horikawa M, Kaufman JA, Farsad K.

AJR Am J Roentgenol. 2018 Apr;210(4):W172. doi: 10.2214/AJR.17.19027. Epub 2018 Feb 15.

PMID:
29446679
23.

Safety and Efficacy of Accelerated Hypofractionation and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients With Varying Degrees of Hepatic Impairment.

Nabavizadeh N, Waller JG, Fain R 3rd, Chen Y, Degnin CR, Elliott DA, Mullins BT, Patel IA, Dyer BA, Fakhoury K, Naugler WE, Farsad K, Tanyi JA, Fuss M, Thomas CR Jr, Hung AY.

Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):577-585. doi: 10.1016/j.ijrobp.2017.11.030. Epub 2017 Nov 27.

PMID:
29413273
24.

Risk factors for stent graft thrombosis after transjugular intrahepatic portosystemic shunt creation.

Jahangiri Y, Kerrigan T, Li L, Prosser D, Brar A, Righetti J, Schenning RC, Kaufman JA, Farsad K.

Cardiovasc Diagn Ther. 2017 Dec;7(Suppl 3):S150-S158. doi: 10.21037/cdt.2017.10.03.

25.

Baseline Tumor Lipiodol Uptake after Transarterial Chemoembolization for Hepatocellular Carcinoma: Identification of a Threshold Value Predicting Tumor Recurrence.

Matsui Y, Horikawa M, Jahangiri Noudeh Y, Kaufman JA, Kolbeck KJ, Farsad K.

Radiol Oncol. 2017 Jul 18;51(4):393-400. doi: 10.1515/raon-2017-0030. eCollection 2017 Dec.

26.

Arteriopathy after transarterial chemo-lipiodolization for hepatocellular carcinoma.

Matsui Y, Figi A, Horikawa M, Jahangiri Noudeh Y, Tomozawa Y, Hashimoto K, Kaufman JA, Farsad K.

Diagn Interv Imaging. 2017 Dec;98(12):827-835. doi: 10.1016/j.diii.2017.10.010. Epub 2017 Nov 20. Erratum in: Diagn Interv Imaging. 2018 Feb 15;:.

27.

ACR Appropriateness Criteria® Iliac Artery Occlusive Disease.

Expert Panel on Interventional Radiology:, Copelan AZ, Kapoor BS, AbuRahma AF, Cain TR, Caplin DM, Farsad K, Knuttinen MG, Lee MH, McBride JJ, Minocha J, Reis SP, Rochon PJ, Shaw CM, Lorenz JM.

J Am Coll Radiol. 2017 Nov;14(11S):S530-S539. doi: 10.1016/j.jacr.2017.08.039.

PMID:
29101990
28.

ACR Appropriateness Criteria® Radiologic Management of Central Venous Access.

Expert Panel on Interventional Radiology:, Shaw CM, Shah S, Kapoor BS, Cain TR, Caplin DM, Farsad K, Knuttinen MG, Lee MH, McBride JJ, Minocha J, Robilotti EV, Rochon PJ, Strax R, Teo EYL, Lorenz JM.

J Am Coll Radiol. 2017 Nov;14(11S):S506-S529. doi: 10.1016/j.jacr.2017.08.053.

PMID:
29101989
29.

Close observation versus upfront treatment in hepatocellular carcinoma: are the exception points worth the risk?

Tholey DM, Hornung B, Enestvedt CK, Chen Y, Naugler WS, Farsad K, Nabavizadeh N, Schlansky B, Ahn J, Jou JH.

BMJ Open Gastroenterol. 2017 Sep 11;4(1):e000157. doi: 10.1136/bmjgast-2017-000157. eCollection 2017.

30.

Tumor Dose Response in Yttrium-90 Resin Microsphere Embolization for Neuroendocrine Liver Metastases: A Tumor-Specific Analysis with Dose Estimation Using SPECT-CT.

Chansanti O, Jahangiri Y, Matsui Y, Adachi A, Geeratikun Y, Kaufman JA, Kolbeck KJ, Stevens JS, Farsad K.

J Vasc Interv Radiol. 2017 Nov;28(11):1528-1535. doi: 10.1016/j.jvir.2017.07.008. Epub 2017 Sep 6.

PMID:
28888827
31.

Percutaneous renal artery revascularization after prolonged ischemia secondary to blunt trauma: pooled cohort analysis.

Jahangiri Y, Ashwell Z, Farsad K.

Diagn Interv Radiol. 2017 Sep-Oct;23(5):371-378. doi: 10.5152/dir.2017.16415.

32.

Mechanisms of Günther Tulip filter tilting during transfemoral placement.

Matsui Y, Horikawa M, Ohta K, Jahangiri Noudeh Y, Kaufman JA, Farsad K.

Diagn Interv Imaging. 2017 Jul - Aug;98(7-8):543-549. doi: 10.1016/j.diii.2017.01.009. Epub 2017 Feb 15.

33.

Exsanguinating Aortoesophageal Fistula: A Herculean Effort.

Morrison JJ, Kharoti Y, Farsad K.

J Vasc Interv Radiol. 2016 Aug;27(8):1226-7. doi: 10.1016/j.jvir.2016.04.037. No abstract available.

PMID:
27449979
34.

Novel Image Guidance Techniques for Portal Vein Targeting During Transjugular Intrahepatic Portosystemic Shunt Creation.

Farsad K, Kaufman JA.

Tech Vasc Interv Radiol. 2016 Mar;19(1):10-20. doi: 10.1053/j.tvir.2016.01.002. Epub 2016 Feb 2. Review.

PMID:
26997085
35.

The Transjugular Intrahepatic Portosystemic Shunt: Technique and Instruments.

Keller FS, Farsad K, Rösch J.

Tech Vasc Interv Radiol. 2016 Mar;19(1):2-9. doi: 10.1053/j.tvir.2016.01.001. Epub 2016 Jan 28. Review.

PMID:
26997084
36.

Introduction.

Farsad K.

Tech Vasc Interv Radiol. 2016 Mar;19(1):1. doi: 10.1053/j.tvir.2016.02.001. Epub 2016 Mar 8. No abstract available.

PMID:
26997083
37.

Practical Tantalum Coating of Microspheres for Experimental Visualization under Fluoroscopy and CT.

Horikawa M, Ishikawa M, Uchida BT, Kaufman JA, Farsad K.

J Vasc Interv Radiol. 2016 Jan;27(1):127-32. doi: 10.1016/j.jvir.2015.07.028.

PMID:
26723923
38.

An Overview of Splenic Embolization.

Ahuja C, Farsad K, Chadha M.

AJR Am J Roentgenol. 2015 Oct;205(4):720-5. doi: 10.2214/AJR.15.14637. Review.

PMID:
26397320
39.

Reply to "Laser ablation for hepatic metastases from neuroendocrine tumors".

Kolbeck KJ, Farsad K.

AJR Am J Roentgenol. 2015 Jun;204(6):W733. doi: 10.2214/AJR.15.14379. No abstract available.

PMID:
26001266
40.

Primary creation of an externally constrained TIPS: a technique to control reduction of the portosystemic gradient.

Farsad K, Kolbeck KJ, Keller FS, Barton RE, Kaufman JA.

AJR Am J Roentgenol. 2015 Apr;204(4):868-71. doi: 10.2214/AJR.14.13104.

PMID:
25794080
41.

Clinical and radiologic evaluation of patients before TIPS creation.

Farsad K, Kolbeck KJ.

AJR Am J Roentgenol. 2014 Oct;203(4):739-45. doi: 10.2214/AJR.14.12999.

PMID:
25247938
42.

Catheter-based treatments for hepatic metastases from neuroendocrine tumors.

Kolbeck KJ, Farsad K.

AJR Am J Roentgenol. 2014 Oct;203(4):717-24. doi: 10.2214/AJR.14.12983. Review.

PMID:
25247935
43.

Pelvic applications of MR-guided high intensity focused ultrasound.

Coakley FV, Foster BR, Farsad K, Hung AY, Wilder KJ, Amling CL, Caughey AB.

Abdom Imaging. 2013 Oct;38(5):1120-9. doi: 10.1007/s00261-013-9999-2. Review.

PMID:
23589077
44.

Transjugular intrahepatic portosystemic shunt creation using intravascular ultrasound guidance.

Farsad K, Fuss C, Kolbeck KJ, Barton RE, Lakin PC, Keller FS, Kaufman JA.

J Vasc Interv Radiol. 2012 Dec;23(12):1594-602. doi: 10.1016/j.jvir.2012.08.023. Epub 2012 Oct 23.

PMID:
23099001
45.

Sacral chordoma.

Farsad K, Kattapuram SV, Sacknoff R, Ono J, Nielsen GP.

Radiographics. 2009 Sep-Oct;29(5):1525-30. doi: 10.1148/rg.295085215. No abstract available.

PMID:
19755609
46.

Computed tomography pulmonary angiography: an assessment of the radiology report.

Abujudeh HH, Kaewlai R, Farsad K, Orr E, Gilman M, Shepard JA.

Acad Radiol. 2009 Nov;16(11):1309-15. doi: 10.1016/j.acra.2009.06.012. Epub 2009 Aug 18.

PMID:
19692272
47.

Computed tomographic angiography as an adjunct to digital subtraction angiography for the pre-operative assessment of cerebral aneurysms.

Farsad K, Mamourian AC, Eskey CJ, Friedman JA.

Open Neurol J. 2009 Jan 28;3:1-7. doi: 10.2174/1874205X00903010001.

48.
49.

RICH-1 has a BIN/Amphiphysin/Rvsp domain responsible for binding to membrane lipids and tubulation of liposomes.

Richnau N, Fransson A, Farsad K, Aspenström P.

Biochem Biophys Res Commun. 2004 Jul 30;320(3):1034-42.

PMID:
15240152
50.

Neurotransmission and the synaptic vesicle cycle.

Farsad K, De Camilli P.

Yale J Biol Med. 2002 Sep-Dec;75(5-6):261-84. Review. No abstract available.

Supplemental Content

Loading ...
Support Center